1Hung S, Chung W, Liou L,et al. HLA-B ^* 5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol [ J]. Proc Natl Acad Scl USA ,2005,102:4134-4139.
2Kaniwa N, Saito Y, Aihara M, et al. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis [ J ]. Pharmacogenomics ,2008,9 ( 11 ) : 1617-1622.
3Lonjou C ,Borot N,Sekula P,et al. A European study of HLA-B in Ste- vens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs [ J ]. Pharnu~cogenet C, enomics,2008,18 ( 2 ) :99-107.
4Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis [ J ]. N Engl J Med, 1995,333 (24) : 1600-1607.
5Lee HY, Pang SM. Thamotharampillai T. Allopurinol-induced Stevens- Johnson syndrome and toxic epidermal necrolysis [ J ]. J Am Acad Der-matol,2008 ,59( 2 ) :352-353.
6Singer JZ, Wallace SL. The allopufinol hypersensitivity syndrome. Un- necessary morbidity and mortality [ J ]. Arthritis Rheum, 1986,29 ( 1 ) : 82-87.
7Zhu Y,Pandya BJ,Choi HK. Prevalence of gout and hyperuricemia in the US general population:the National Health and Nutrition Examination Survey 2007-2008[J].Arthritis and Rheumatism,2011.3136-3141.
8Singh JA,Reddy SG,Kundukulam J. Risk factors for gout and prevention:a systematic review of the literature[J].Current Opinion in Rheumatology,2011.192-202.
9Martin WJ,Walton M,Harper J. Resident macrophages initiating and driving inflammation in a monosodium urate monohydrate crystal-induced murine peritoneal model of acute gout[J].Arthritis and Rheumatism,2009.281-289.
10Liu-Bryan R,Scott P,Sydlaske A. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal induced inflammation[J].Arthritis and Rheumatism,2005.2936-2946.
